Author/Authors :
Pourhoseingholi، Mohamad Amin نويسنده Research Center for Gastroenterology and Liver Disease, Shahid Beheshti University of Medical Sciences, Tehran, Iran , , Faghihzadeh ، S نويسنده Department of Biostatistics, Department of Biostatistics, Tarbiat Modares University, Tehran, Iran, Tehran, Iran , , Hajizadeh ، E نويسنده Department of Biostatistics, Tarbiat Modares University, Tehran, Iran , , Gatta ، G نويسنده Institute Nazionale Tumori, Via Venezian 1, Milan, Italy , , Zali، MR نويسنده , , Abadi، AR نويسنده ,
Abstract :
Background: Cancer is the third most common cause of death in Iran. Gastric
cancer (GC) and colorectal cancer (CRC) are two important causes of mortality
due to cancer. With regards to cancer mortality, data are important to monitor the
effects of screening program, earlier diagnosis, demographic data and other
prognostic factors. The aim of this study was to evaluate the mortality rates and
trends from GC and CRC in Iranian population during a period of almost a
decade, i.e. from 1995 to 2003.
Methods: National death Statistic Reported by the Ministry of Health and Medical
Education (MOH&ME) from 1995 to 2003, stratified by age group, sex, and
cause of death are included in this study. CRC and GC were expressed as the
annual mortality rates/100,000, general and/or per gender, and age group.
Results: The general mortality rate of CRC slightly increased during the years
under study from 0.44 to 2.54 and CRC mortality was higher for older age and
male. The general mortality rates of GC showed a sharp increasing from 1.68 to
9.67. In addition to this, GC mortality rate was higher for male than female.
Conclusion: Our study indicated remarkable increasing trends in GC and CRC
mortality. So developing for a gastric cancer for both primary prevention and
early detection programs and manage the delays of diagnosis is recommended to
decrease the trend of GC mortality. For CRC, since the rate of CRC screening is
very low in Iran, it is recommended that in Iran screening be started as a public
program in order to control the mortality and burden of CRC in the future.